Skip to main content

Bag This Bargain Even Cheaper Than Chief Commercial Officer Yarema Did

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on June 14, Atara Biotherapeutics Inc's Chief Commercial Officer, Kristin Yarema, invested $500,369.64 into 34,354 shares of ATRA, for a cost per share of $14.57..
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.